Clinical Trials Browser

Phase 1/2 × Astrocytoma × Imatinib Mesylate × Clear all

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00021229 2014-07-31

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Phase 1/2 Terminated

85 enrolled 17 charts

CNS

Astrocytoma, Central Nervous System Neoplasms

Clinical Trials

Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma